In a recent review Louise Olofsson and Fredrik discuss how the gut bacterial composition is altered in, and may contribute to, cardiometabolic disease, as well as how the gut bacteria can be targeted to treat and prevent metabolic diseases.
Review article, Endocrine Reviews, 30 January 2022:
Wallenberg Laboratory/Sahlgrenska University Hospital
Bruna Stråket 16, level 2/3
SE-413 45 Göteborg
SWEDEN
Wallenberg Laboratory/Sahlgrenska University Hospital
Bruna Stråket 16, level 2/3
SE-413 45 Göteborg
You can also reach our Lab via the main entrance at Sahlgrenska Hospital,
Blå Stråket 5, Entrance H
Our research group takes a translational research approach to investigate how the gut microbiota contributes to cardiometabolic disease.
We aim to increase the knowledge of the metagenome and explore how metabolites interacts in the processes for developing T2D and CVD.
© Bäckhed Lab